Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
Significance: This study suggests, for the first time, Interleukin-37 (IL-37), by increasing the expression of its target gene, it may suppress the expression of stem cell protein Oct-4. Thus, pharmacological formulations encompassing “IL-37 or its activators” can be used to inhibit cancer stem cell proliferation.
Citation: Boominathan, Interleukin-based anti-cancer therapy: Interleukin-37 (IL-37) suppresses the expression of stem cell protein Oct-4 via up regulation of its target gene, 22/March/2015, 22.28, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Courtesy: When you cite drop us a line at email@example.com
Undisclosed information: How IL-37 decreases the expression of Stem cell protein Oct-4
* Research cooperation